Hansa Medical to present IdeS at the World Orphan Drug Congress USA, April 24 in Washington D.C.
10 Apr 2014, 13:00
The presentation focusing on Hansa Medical’s lead drug-candidate IdeS’ capacity for desensitization prior to kidney transplantation is scheduled for 3:15 pm on April 24.
The World Orphan Drug Congress USA will be held on April 23-25 at the Grand Hyatt Washington, Washington D.C. For more information about the event please visit: www.terrapinn.com/2014/world-orphan-drug-congress-usa.
The company presentation’s emphasize will be on its lead drug-candidate IdeS, IdeS’ recent clinical Phase I results and IdeS’ forthcoming Phase II studies in 2014.
For further information, please contact:
Hansa Medical AB
Emanuel Björne, CEO Hansa Medical AB (publ)
Mobile: 46 707 17 54 77